TcLand Expression is a pioneer and recognized leader in gene expression biomarkers for unmet medical needs in transplantation and auto-immune diseases. The company was founded in 2002 in Nantes, France as a spin-off from ITERT one of the world’s leading Research Institutes in transplantation and immunology. The company benefits from an exceptional scientific environment and focuses on two major therapeutic areas with huge remaining unmet needs: transplantation and auto-immune diseases. The company also performs immunological tests (repertoire analysis -TcLandscape, BcLandscape - as well as additional immunomonitoring tests within the CIMNA platform) for pharmaceutical and biotechnology companies conducting clinical trials in oncology, auto-immune diseases, vaccination and transplantation.